Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 13/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2608172 | 0.98 | ACHE (0.41) | ACHETSHRALDH1A1KDM4EMAPK1 | |
| SCHEMBL2608179 | 0.88 | MEN1 (0.39) | ACHETSHRALDH1A1 | |
| SCHEMBL2612360 | 0.84 | ALDH1A1 (0.45) | ACHETSHRALDH1A1KDM4EMAPK1 | |
| SCHEMBL16803336 | 0.84 | TSHR (0.50) | ACHETSHRKDM4EMAPK1HIF1A | |
| SCHEMBL340563 | 0.83 | ALDH1A1 (0.41) | ACHETSHRALDH1A1 | |
| SCHEMBL10081653 | 0.83 | FAAH (0.45) | ACHETSHRALDH1A1KDM4EMAPK1 | |
| SCHEMBL29100282 | 0.81 | TSHR (0.61) | ACHETSHRKDM4EMAPK1HIF1A | |
| SCHEMBL21122833 | 0.81 | ACHE (0.40) | ACHETSHRKDM4EMAPK1HIF1A | |
| SCHEMBL29100295 | 0.81 | TSHR (0.61) | ACHETSHRKDM4EMAPK1HIF1A | |
| SCHEMBL2608239 | 0.81 | ALDH1A1 (0.58) | TSHRALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8158021-B2 | Polymerizable liquid crystal compound, polymerizable liquid crystal composition, liquid crystalline polymer, and optical anisotropic article | ZEON CORPORATION (JP) | 2012-04-17 | — | — | US | disclosed |
| US-20100258764-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTALLINE POLYMER, AND OPTICAL ANISOTROPIC ARTICLE | ZEON CORPORATION (JP) | 2010-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100258764-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTALLINE POLYMER, AND OPTICAL ANISOTROPIC ARTICLE | LEO1, ZYX, CCNT1 | ACHE 4310/4885TSHR 4760/4885ALDH1A1 2720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.